Jessica C. Hassel
University Hospital Heidelberg
2 papers in the Anchorcite directory, published between 2010 and 2014, cited 21,049 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 2 papers
- Cutaneous Melanoma Detection and Management · 2 papers
- Immunotherapy and Immune Responses · 1 paper
- Melanoma and MAPK Pathways · 1 paper
Frequent co-authors
- Caroline Robert · 2 papers
- Dirk Schadendorf · 2 papers
- Célèste Lebbé · 2 papers
- Frank Stephen Hodi · 1 paper
- Steven J O'Day · 1 paper
- David F. McDermott · 1 paper
- Robert W. Weber · 1 paper
- Jeffrey Alan Sosman · 1 paper
Papers
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine · 2010 · 15,401 citations
BACKGROUND: An improvement in overall survival among patients with metastatic melanoma has been an elusive goal. In this phase 3 study, ipilimumab--which blocks cytotoxic T-lymphocyte-associated antigen 4 to potentiate an antitumor T-cell response--administered with or without a glycoprotein 100 (gp100)…
- Nivolumab in Previously Untreated Melanoma without BRAF MutationNew England Journal of Medicine · 2014 · 5,648 citations
BACKGROUND: Nivolumab was associated with higher rates of objective response than chemotherapy in a phase 3 study involving patients with ipilimumab-refractory metastatic melanoma. The use of nivolumab in previously untreated patients with advanced melanoma has not been tested in a…
Metadata from OpenAlex (CC0).